Neuronetics, Inc. is a medical device company focused on developing and commercializing non-invasive therapies to treat chronic psychiatric and neurological disorders.
Employees: 51-200
Total raised: $64M
Investors 3
Funding Rounds 2
| Date | Series | Amount | Investors |
| 27.04.2015 | Series F | $34M | - |
| 16.05.2011 | Series E | $30M | - |
Mentions in press and media 13
| Date | Title | Description | Source |
| 11.03.2024 | Neuroplasticity Market by Bright Future Trends, Drivers, Res... | Neuroplasticity Market Report BURLINGAME, CALIFORNIA, UNITED STATES, March 11, 2024 /EINPresswire.co... | einpresswi... |
| 07.03.2024 | Neuronetics Announces 5-Year Exclusive Partnership with Tran... | - | globenewsw... |
| 05.03.2024 | Neuronetics Reports Record Fourth Quarter and Record Full Ye... | - | globenewsw... |
| 07.06.2017 | Term Sheet — Wednesday, June 7 | 500 Hello, it’s Fortune 500 day! The 2017 list is live here. For 63 years, this list has ranked the ... | fortune.co... |
| 06.06.2017 | Neuronetics, Inc. Raises $15 Million in Series G Equity Fina... | - | ascensionv... |
| 06.06.2017 | Neuronetics Raises $15M Series G | Neuronetics, Inc., a privately held medical device company widely recognized as the market-leader in... | citybizlis... |
| 06.06.2017 | Neuronetics Raises $15M in Series G Equity Funding | Neuronetics, Inc., a Malvern, Pa.-based medical device company, closed on a $15m Series G funding. B... | finsmes.co... |
| 14.05.2015 | Neuronetics raises $34m for anti-depression device | Neuronetics said it raised $34.3 million in an equity offering slated to help broaden the use of its... | massdevice... |
| 27.04.2015 | Neuronetics Completes $34M Series F Financing | Neuronetics, Inc., a Malvern, PA-based provider of transcranial magnetic stimulation (TMS) technolog... | finsmes.co... |
| 17.06.2013 | Medical Devices: What does it really mean to be disruptive? | By Amy Siegel & Tim Kofol, S2N Health In our line of work, we come across many innovative medica... | massdevice... |
Show more